Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

02. Novembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2867


	Articles 1 - 20 / 57333

	Evaluation of factors associated with drug fever following gemcitabine and nanoparticle albumin-bound paclitaxel treatment for pancreatic cancer. Support Care Cancer Saito Y, Takekuma Y, Komatsu Y, Sugawara M. PMID: 41175273 [PubMed - indexed for MEDLINE]
	Spermine synthase in Snyder-Robinson syndrome and cancer. Mol Biol Rep Yerlikaya A. PMID: 41175261 [PubMed - indexed for MEDLINE]
	Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials. Immunotherapy Coschi CH, Ding K, Tu D, O'Callaghan C, Leighl NB, Vera-Badillo F, Juergens RA, Hao D, Seymour L, Renouf DJ, Chen E, Fung AS, Gaudreau PO. PMID: 41175109 [PubMed - as supplied by publisher]
	Brain metabolic vulnerability in 18-F FDG PET/CT predict future depression risk in young cancer survivors. Transl Psychiatry Liu N, Sun J, Jiang Y, Bai S, Wang Y, Lu J, Wang W, Zhu P, Jian G, Zeng J, Wang X, Chen J, Ma Y. PMID: 41173826 [PubMed - indexed for MEDLINE]
	The future of pancreatic cancer therapy: getting better, but not good enough yet. Arch Med Res Klose J, Doebereiner J, Sunami Y, Rebelo A, Ronellenfitsch U, Kleeff J. PMID: 41172872 [PubMed - as supplied by publisher]
	Updates and Review of Neoadjuvant Therapy for Resectable Pancreatic Cancer. Oncology Cobb W, Rozefort D, Ji C, Sehgal S, Rosales A, Sehgal R. PMID: 41171974 [PubMed - as supplied by publisher]
	Opportunities to Avoid Invasive Cancer by Diagnosis and Interception of Preneoplastic Lesions and Cancer Risk Conditions. Cancer Epidemiol Biomarkers Prev Pradhan P, Ghobrial IM, Marinac CR, O'Donnell EK, Syngal S, Weeks LD, Rebbeck TR. PMID: 41171434 [PubMed - as supplied by publisher]
	Associations between lifestyle factors and excess mortality of cancer patients in Finland: A pooled analysis of seven population-based cohort studies. Int J Cancer Peltola I, Seppä K, Heikkinen S, Eriksson JG, Härkänen T, Jousilahti P, Knekt P, Koskinen S, Männistö S, Rahkonen O, Malila N, Laaksonen MA, Pitkäniemi J. PMID: 41170866 [PubMed - as supplied by publisher]
	Extra-pancreatic malignancies in patients with intraductal papillary mucinous neoplasms. Expert Rev Gastroenterol Hepatol Orzan RI, Khoury T. PMID: 41170741 [PubMed - as supplied by publisher]
	Oxidative stress and pancreatic cancer: a dual role in tumorigenesis and drug toxicity. Toxicol Res Limbu KR, Chhetri RB, Oh YS, Oak MH, Beak DJ, Park EY. PMID: 41169274 [PubMed]
	Stereotactic body radiation therapy for inoperable non-metastasized pancreatic adenocarcinoma: a randomised phase II study (TORPEDO). BMC Cancer Stas D, Vandamme T, Roeyen G, Reynders D, Demey W, Stellamans K, Bussels B, Hutsebaut I, Maurissen I, Bouchart C, Berbée M, Lallemand F, Poels H, Thomas M, Cuyle PJ, Bulens P, Verboven K, Martens M, Weytjens R, Joye I. PMID: 41168707 [PubMed - indexed for MEDLINE]
	HypoxamiRs in pancreatic cancer: master regulators of the hypoxic tumor microenvironment. Cell Biol Toxicol Salehi-Sangani P, Maharati AH, Payami B, Aliakbarian M, Abbaszadegan MR. PMID: 41168410 [PubMed - indexed for MEDLINE]
	Anamorelin in Cancer Cachexia: Gut Microbiota Effects and CONUT Score as a Predictor of Response. In Vivo Boku S, Yasuda T, Ikoma T, Matsumori E, Yoshiuchi S, Matsuo Y, Higasa K, Kurata T. PMID: 41167673 [PubMed - indexed for MEDLINE]
	Organ-specific cancer risks following exposure to radiation can be explained by a shift of spontaneously arising cancers toward younger ages. Int J Radiat Biol Nakamura N. PMID: 41166441 [PubMed - as supplied by publisher]
	Outcomes of conversion surgery following chemotherapy for initially unresectable metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study in Taiwan. J Cancer Res Clin Oncol Su PJ, Lu WH, Liao TK, Wang CJ, Chao YJ, Shan YS. PMID: 41165833 [PubMed - indexed for MEDLINE]
	The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA. Cancer Commun (Lond) Luo HY, Wei W, Li P, Zhang QH, Zhou Z, Cui L, Lin YB, Yang H, Zhong X, Liu Q, Yang H, Luo KJ, Qiu HB, Yuan SQ, Li YF, Zhou ZW, Lin XJ, Cui BK, Zhang RX, Fan WH, Huang H, Lan CY, Li JD, Wang ZQ, Li BK, Guo RP, Tang J, Huang X, Xi M, Liu Y, Xie C, Chen S, Li ZH, Liu YH, Zhang XT, Zeng Q, Yi X, Xu RH. PMID: 41165038 [PubMed - as supplied by publisher]
	Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk. Front Immunol Ma Z, Wang S, Liu S, Yang W, Hu J, Lv L, Yu Q, Lu Y. PMID: 41164182 [PubMed - indexed for MEDLINE]
	Mesothelin in pancreatic cancer: clinical applications and analytical considerations. Clin Chim Acta Patel N, Gupta A, Misra R, Menon SV, Ray S, Pandey SN, Goyal K, Ali H, Maji C, Rekha A, Gupta G, Hussain MS. PMID: 41161565 [PubMed - as supplied by publisher]
	Performance of Immunohistochemistry to Detect Rb/p53 Alterations in High-Grade Neuroendocrine Neoplasms: Staining Patterns and Comparison with Genetic Testing. Endocr Pathol Chen R, Tihy M, Lacroix L, de Rycke O, Lacombe C, Just PA, Cazes A, Svrcek M, de Montpreville VT, Antoine M, Scoazec JY, de Mestier L, Couvelard A, Cros J. PMID: 41160312 [PubMed - indexed for MEDLINE]
	Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma. Cancer Cytopathol Yang R, Gereg C, Olave MC, Yoon E, Cai G. PMID: 41159799 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 57333

Page 1 de 2867



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité